Metabolic Alkalosis and Hypokalemia
내과 나기량
Definition of Metabolic Alkalosis
Metabolic alkalosis is a common primary acid-base disturbance manifested by
an elevated arterial pH, increased bicarbonate, and increased PaCO2-
Often, but not always accompanied by hypochloremia and hypokalemia
CNUH Renal Division
Differential Diagnosis of an elevated serum HCO3- and Low Cl Metabolic alkalosis
Respiratory acidosis (Chronic)
: renal compensation ↑ HCO3 Therefore, diagnosis requires a concomitant arterial pH.
CNUH Renal Division
Respiratory compensation for MAK
PaCO2 will increase 6 mmHg for each 10 mEq/L increase in the [HCO3-] PaCO2 will increase 0.75 mmHg per mEq/L increase in the [HCO3-] PaCO2 = HCO3- + 15
When HCO3- in the range of 10-40 mEq/L
CNUH Renal Division
For Example!!
CHF on Diuretics medication(furosemide)
ABGA : 7.49 - ( ? /75) – 30 – 95% Na / K / Cl ( 134 / 3.4 / 93 ) Δ HCO3- = 30-24 = 6
Q : Estimated PaCO2 ? A
HCO3- (30)+ 15 = 45 mmHg ΔPaCO2 = Δ HCO3-(6)x 0.75 = 4.5
CNUH Renal Division
Renal physiology : + and HCO K 3
Determinants of Plasma Potassium Concentration
• Total content of K : 3500 mmol • ECF K content : 60-65 mmol (2%) • Internal Balance - transfer ECF↔ICF • External balnce - Renal K balance - Dietary K balnce
Renal handling of potassium
65~70%
Distal convoluted tubule
Cortical collecting duct
100%
30%
10~15%
Proximal convoluted tubule 25%
50%
TAL
50%
Outer medullary collecting duct
FE K+ =
[K+]u[Cr]s [K+]s[Cr]u
30% x100
K+
140%
Medullary collecting duct
=10-20% or ~90mmol/day
Fractional excretion of K+
Renal K+ transport in Proximal tubule
Electrolyte transport in the thick ascending limb
Lumen
Ca2+, Mg 2+
Blood
Na+/K+/2Clco-transporter
Cl- channel Cl-
Na+
K+
(CIC-kb)
2K + 3Na+ Na+/K+ ATPase
2 Cl-
furosemide
ATP sensitive K+ channel
K+ K+ Cl-
Apical
membrane
Basolateral
membrane
Collecting tubule principal cell: K+ secretion
Lumen
Epithelial Na+
Aldosterone
Blood
3Na+
Channel
Na+
ENaC
K+
Amiloride
+ +
+
2K +
Na+/K+ ATPase Mineralocorticoid receptor
H+ K+
► K secretion factor
1. Luminal flow rate & distal Na delivery
2. Aldosterone 3. ECF K
Apical
membrane
4. Extracellular pH
Basolateral
membrane
Collecting tubule intercalated cell :
K+ reabsorpton
Lumen
3Na+ 2K +
Blood
Na+/K+ ATPase
K+ H+
Antiporter
K+
K+ channel
Apical
membrane
Basolateral
membrane
Pathophysiology : Phase of MAK
Generative Stage
Loss of acid ( vomiting, NG suction, diuretics ) Gain of HCO3- (renal or extrarenal sources) Primary aldosteronism
Maintenance Stage (kidney loses ability to excrete bicarbonate efficiently)
Volume contraction, low GFR, Cl- or K+ depletion, high PCO2-, 2ndary hyperaldosteronism
CNUH Renal Division
Enteric Fluid Volume and Mineral Content
Liter/da Na Saliva 1-2 10 60 150 100 K 30 9 10 5 100 Cl 10 90 90 100 15 HC03 30 0 70 20 60
Gastric Juice 2 Bile 2-3
Small Bowel 1 Colon
Variable 40
(mEq/L)
CNUH Renal Division
HCO3- Retention by the Kidney
Cl- deficiency(ECF contraction), K+ deficiency, decrease in GFR and/or enhanced proximal bicarbonate absorption
2ndary hyperreninemic hyperaldosteronism
Stimulates H+ secretion in CCT Repair with saline and K+ administration
Hypermineralocorticoidism and K+ deficiency induced by autonomous factors unresponsive to volume feedback
Stimulation of H+ secretion in CCT >> effect of vol expansion to suppress proximal Na+/H+ Repair by surgical or phamacological means not by saline
CNUH Renal Division
Causes of Metabolic Alkalosis : Clinical situation
Vol. Contraction, hypokalemia
Vomiting, NG suction Renal loss of H+, Cl-, and K+, diuretics, drug anions, magnesium deficiency
Vol. Expansion, hypertension, hypokalemia
High or Low renin (renal artery stenosis, adrenal adenoma)
Exogenous bicarbonate loads
CNUH Renal Division
ECF contraction, Normal BP, Hypokalemia and 2ndary hyperaldosteronism
Gastrointestinal origin
Vomiting and NG suction Congenital chloridorrhea Villous adenoma
Renal origin
Diuretics, edematous states Mg+2 deficiency and hypoparathyroidism Bartter and Gitelman syndrome Non-reabsorbable anions (penicillin & carbeniciilin) Recovery from lactic or ketoacidosis (overshoot)
CNUH Renal Division
Pathways and mediators of Na+ reabsorption
NCCT
Proximal tubule
Distal tubule
Gitelman syndrome
Na+ 7%
Na+ 60%
Na+ 30%
Na+ 2% Epithelial Na+ channel
Na+/K+/2Cl- co-transporter Renal outer medullary K+ channel Cl- channel Loop of Henle
Liddle’s syndrome PHA type I
Bartter’s syndrome
CNUH Renal Division
Furosemide action in the thick ascending limb
Lumen
Ca2+, Mg 2+ Na+/K+/2Clco-transporter (furosemide sensitive) Cl- channel
Blood
ClNa+
(CIC-kb) 2K + 3Na+ Na+/K+ ATPase
K+ 2 Cl-
furosemide
ATP sensitive K+ channel
K+
K+ Cl-
Apical
membrane
Basolateral
membrane
Lumen
Na+ ClThiazide
Blood
Ca2+ Na+ 2K+
TSC
ATP ATP
ECaCl Ca++
3Na+ Ca2+
Cl-
Cell
Thiazide at distal tubule
ECF Expansion, Hypertension, Hypokalemia and mineralocorticoid excess
High Renin
Renal artery stenosis Renin-secreting tumor Estrogen therapy Accelerating hypertension
Low Renin
Primary aldosteronism
adenoma, carcinoma, hyperplasia
Adrenal enzyme defects
11β or 17α hydroxylase deficiency
Cushing syndrome
pituitary, adrenal adenoma, ectopic
Other’s
Licorice, carbenoxolone, chewer’s tobacoo, Liddle’s syndrome
CNUH Renal Division
Collecting tubule principal cell: K+ secretion
Lumen
Epithelial Na+
Aldosterone
Blood
3Na+
Channel
Na+
ENaC
Amiloride
+ +
+
(amiloride sensitive) K+
2K +
Na+/K+ ATPase Mineralocorticoid receptor
H+ K+
Apical
membrane
Basolateral
membrane
• Excessive Na reabsorption HT, Vol exp, Renin↓
• Functional coupling of Na Reabsorption to K and H Secretion in distal nephron MAK, HypoK
증 례
Case1
C.C : Hypokalemia로 consulted (NR) P.I ( 69/M )
신경과에서 gait disturbance로 입원치료중 hypertension, hypokalemia, renal insufficiency로 consulted HT은 3달전 진단, DM(-)
P/Ex : Abdominal bruit (Rt flank)
Lab
ABGA : 7.43-42/84-28-96% S-Na/K/Cl (137.6/2.1/93.8) , U-Na/K/Cl (44.8/24.9/60.0) BUN/Cr (24.8/1.95), 24hr UP=2.5 g, Ccr=31.2 ml/min
CNUH Renal Division
Case1
Kidney Sono
10.8 cm
7.2 cm
Renin: 45.4 ng/ml/hr (0.15~2.33), Angiotensin 5193 pg/ml
CNUH Renal Division
Case1:Renal angiography
CNUH Renal Division
Case1-Ballooning
CNUH Renal Division
Case2
C.C : Facial edema w Wt gain. (6Mo PTA)
(53 kg 62 kg)
P.I :
03’11월 부터 상기 Sx과 손,발의 저림, flushing 있어 선병원에서 검진함 : HBP, K 3.2 adal30mg, DCZ 25mg,ASA 100mg 항고혈압 약제 복용후 증상의 호전 없고 충혈, 안구 건조 및 입마름 증상 진행되어 내원
P/Ex
V/S : 110/80 – 70 -20 -36.7oC Puffy face, anxious mood, Buffallo hump (?)
CNUH Renal Division
Case 2
LAB
ABGA : 7.44-43/106-29-99 S-Na/K/Cl (144/2.7/101), U-Na/K/Cl (28/39/38) Hormone study
Renin (0.83) (ng/ml/h:0.15-2.33) aldosterone (4.7) (ng/dl:1.0-16) serum cortisol 34.2-> 28.7 24hr urine cortisol : 837
CNUH Renal Division
Case 2 - Brain MRI
CNUH Renal Division
CNUH Renal Division
Case 3
C.C : Sudden Visual Acuity ↓ (3D PTA) P.I
1년전 HBP Dx (No medication) 2개월 전부터 headache, nocturia발생
P/Ex
V/S 220/90-96-20-36.7oC NVE (+) No PPh edema
CNUH Renal Division
Case3
LAB
ABGA : 7.41-41/88-25.8-97% S-Na/K/Cl (130/2.5/96), U-Na/K/Cl (24/24/37) BUN/Cr (93/8.5) Ccr = 6.5 ml/min, 24h UP = 706 mg/d Hormone study
Renin (2.7) (ng/ml/h:0.15-2.33) aldosterone (42.5) (ng/dl:1.0-16) Cortisol : WNL
CNUH Renal Division
Case3-Abd MRI
CNUH Renal Division
To make a long story short !!!
Hypertension and Hypokalemia
• Plasma renin activity (PRA) •Plasma aldosterone concentration (PAC)
↑PRA ↑PAC PAC-PRA≈10
Investigate for causes of 2nd hyperaldosteronism
•RVHT
•Diuretic use •Renin secreting tumor
↓PRA ↑PAC PAC-PRA≥10 And PAC ≥ 15ng/dL
↓PRA ↓PAC PAC-PRA≈10
Investigate for
•Cong Adr Hyperplasia •Exoge mineralocorticoid •DOC-producing tumor
Investigate for Primary aldosteronism
•Cushing’s synd •11-β-OHSD deficiency
•Altered aldo metabolism •Liddle’s syndrome
•Malignant Phase HT
•Coa of aorta
When to consider Screening for Primary Aldosteronism
• Hypertension and Hypokalemia
• Resistant Hypertension • Adrenal Incidentaloma and HBP
• Whenever considering 2nd HBP • Morning blood sampling in seated ambulant pt:
Plasma renin activity (PRA) Plasma aldosterone concentration (PAC)
PRA↓ PAC↑ PAC-PRA ratio ≥ 20 ng/dL per ng/mL per hr And PAC ≥ 15ng/dL(≥416 pmol/L)
Investigate for Primary aldosteronism
CNUH Renal Division
감사합니다!!
Confirmed Primary aldosteronism
CNUH Renal Division
Treatment options for 1o Aldo
CNUH Renal Division